Acadia Pharmaceuticals | ACAD - Equity Capital And Reserves


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Acadia Pharmaceuticals

Acadia Pharmaceuticals reported $374.26M in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.


Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 374.26M 26.15M
ALKERMES ALKS:US USD 1.01B 38.18M
Alnylam Pharmaceuticals ALNY:US USD -259240000 101.02M
Biogen BIIB:US USD 13.8B 398.7M
BioMarin Pharmaceutical BMRN:US USD 4.66B 55.89M
Cara Therapeutics CARA:US USD 136.6M 22.18M
Corcept Therapeutics CORT:US USD 529.58M 27.74M
Cytokinetics CYTK:US USD -229020000 121.12M
Eisai 4523:JP JPY 799.96B 25.92B
Eli Lilly LLY:US USD 11.19B 540.6M
Incyte Corp INCY:US USD 4.46B 92.45M
Intercept Pharmaceuticals ICPT:US USD 67.18M 25.89M
Intra Cellular Therapies ITCI:US USD 627.61M 28.46M
J&J JNJ:US USD 70.87B 5.94B
Marinus Pharmaceuticals MRNS:US USD 85.08M 30.92M
Moderna Inc MRNA:US USD 18.86B 260M
Neurocrine Biosciences NBIX:US USD 1.68B 23.3M
Prothena PRTA:US USD 607.41M 14.63M
PTC Therapeutics PTCT:US USD -457561000 110.48M
Sarepta Therapeutics SRPT:US USD 712.75M 327.8M
Seattle Genetics SGEN:US USD 2.72B 80.66M
Ultragenyx Pharmaceutical RARE:US USD 220.48M 132.01M
Vanda Pharmaceuticals VNDA:US USD 535.74M 8.54M
Vertex Pharmaceuticals VRTX:US USD 14.43B 519.6M